Rothschild, S. I. (2016). New treatment options for ALK+ advanced non-small-cell lung cancer: Critical appraisal of ceritinib. Ther Clin Risk Manag.
Citação norma ChicagoRothschild, Sacha I. "New Treatment Options for ALK+ Advanced Non-small-cell Lung Cancer: Critical Appraisal of Ceritinib." Ther Clin Risk Manag 2016.
MLA CitationRothschild, Sacha I. "New Treatment Options for ALK+ Advanced Non-small-cell Lung Cancer: Critical Appraisal of Ceritinib." Ther Clin Risk Manag 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.